Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$1.32B |
| 2 |
AstraZeneca
AZN
|
+$733M |
| 3 |
Microsoft
MSFT
|
+$728M |
| 4 |
Cadence Design Systems
CDNS
|
+$720M |
| 5 |
Moody's
MCO
|
+$359M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$1.43B |
| 2 |
Estee Lauder
EL
|
+$872M |
| 3 |
Eli Lilly
LLY
|
+$626M |
| 4 |
Netflix
NFLX
|
+$521M |
| 5 |
UnitedHealth
UNH
|
+$466M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.19% |
| 2 | Consumer Discretionary | 19.62% |
| 3 | Healthcare | 16.16% |
| 4 | Financials | 9.12% |
| 5 | Communication Services | 8.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
AT&T
T
$162B
| $16M | 0.01% |
828,672
-868,415
| -51% | -$16.6M |
|
352
Jack Henry & Associates
JKHY
$11.2B
| $15.6M | 0.01% |
103,492
-16,493
| -14% | -$2.75M |
|
353
BCE
BCE
$21.2B
| $15.3M | 0.01% |
341,931
-1,610
| -0.5% | -$72.7K |
|
354
Deckers Outdoor
DECK
$13.3B
| $14.5M | 0.01% |
192,876
+175,938
| +1,039% | +$12.3M |
|
355
Lattice Semiconductor
LSCC
$18.3B
| $14.3M | 0.01% |
150,128
+144,733
| +2,683% | +$11.9M |
|
356
Cousins Properties
CUZ
$4.91B
| $14M | 0.01% |
657,080
-1,015,174
| -61% | -$24.7M |
|
|
HRT
357
DELISTED
HireRight Holdings Corporation
HRT
| $13.6M | 0.01% |
1,278,253
+34,202
| +3% | +$385K |
|
358
Chewy
CHWY
$9.59B
| $13.4M | 0.01% |
358,338
-83,714
| -19% | -$3.47M |
|
|
RXDX
359
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $13.1M | 0.01% |
122,495
+57
| +0% | +$6.56K |
|
360
Dow Inc
DOW
$21.9B
| $13.1M | 0.01% |
238,721
+8,233
| +4% | +$463K |
|
|
HOLX
361
DELISTED
Hologic
HOLX
| $13M | 0.01% |
161,218
-262,025
| -62% | -$21.1M |
|
362
Kinetik
KNTK
$3.69B
| $13M | 0.01% |
415,083
| – | – |
|
363
Corteva
CTVA
$51.3B
| $12.7M | 0.01% |
211,391
+1,757
| +0.8% | +$107K |
|
|
TXNM
364
TXNM Energy Inc
TXNM
$5.92B
| $12.5M | 0.01% |
257,556
-734,271
| -74% | -$36M |
|
365
Expedia Group
EXPE
$36.8B
| $12.5M | 0.01% |
129,118
-118,857
| -48% | -$12.5M |
|
366
Canadian National Railway
CNI
$76.5B
| $12.5M | 0.01% |
106,146
-23,454
| -18% | -$2.77M |
|
|
BRKL
367
DELISTED
Brookline Bancorp
BRKL
| $12.4M | 0.01% |
1,179,714
+37,843
| +3% | +$477K |
|
368
Q2 Holdings
QTWO
$3.95B
| $12.3M | 0.01% |
497,763
-408
| -0.1% | -$12.1K |
|
369
Construction Partners
ROAD
$5.66B
| $12.2M | 0.01% |
453,329
+100,013
| +28% | +$2.72M |
|
370
Bunge Global
BG
$20.9B
| $11.7M | 0.01% |
122,853
+11,686
| +11% | +$1.14M |
|
|
TE
371
T1 Energy
TE
$1.55B
| $11.7M | 0.01% |
1,313,182
-3,197
| -0.2% | -$27.8K |
|
372
Devon Energy
DVN
$49.7B
| $11.5M | 0.01% |
227,685
-338,488
| -60% | -$19.3M |
|
373
Eaton
ETN
$174B
| $11.4M | 0.01% |
+66,516
| New | +$11.1M |
|
374
Atlantic Union Bankshares
AUB
$6.02B
| $11.3M | 0.01% |
323,295
-27,480
| -8% | -$1.02M |
|
375
Avantor
AVTR
$8.91B
| $11.2M | 0.01% |
530,840
-126,063
| -19% | -$2.87M |
|
Similar funds
Jennison Associates's Q1 2023 Portfolio in Review
As of Q1 2023, Jennison Associates held 644 positions worth $109B, up 10% from $98.7B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Jennison Associates withdrew a net $3.94B in Q1 2023, closing 63 positions and reducing 280 holdings. Its most notable exit was Alcon, an estimated $1.43B position sold in full.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jennison Associates opened a new position in Advanced Micro Devices worth $1.59B.
- Jennison Associates's largest Q1 2023 buy was Advanced Micro Devices: 16,272,765 shares worth $1.59B.
- Jennison Associates added most to AstraZeneca in Q1 2023, an estimated $733M increase.
- Jennison Associates's biggest Q1 2023 reduction was Estee Lauder, cutting an estimated $872M.
- Jennison Associates fully exited Alcon in Q1 2023, selling an estimated $1.43B.
- Jennison Associates's ten largest holdings make up 39% of its $109B portfolio in Q1 2023.
- Jennison Associates opened 73 new positions and closed 63 in Q1 2023.
- Jennison Associates's portfolio value rose 10% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q1 2023, filed 26 Apr 2023.